VALIRX PLC
VAL | IL
Overview
Corporate Details
- ISIN(s):
- GB00BLH13C52
- LEI:
- 213800VQKB9SJCQDET40
- Country:
- United Kingdom
- Address:
- STONEBRIDGE HOUSE, CM22 7BD HATFIELD HEATH
- Website:
- https://www.valirx.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
ValiRx PLC is a life science company focused on the early-stage development of therapeutics and diagnostics, primarily in the fields of oncology and women's health. The company's strategy is to accelerate the translation of innovative science into clinical-stage treatments. ValiRx provides scientific, financial, and commercial support to progress its collaborative pipeline of drug candidates, with expertise in epigenomic and genetic analysis. Through its subsidiary, Inaphaea BioLabs, the company offers preclinical and evaluation services, aiming to create an integrated approach to the diagnosis, treatment, and prognosis of diseases to improve patient lives.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for VALIRX PLC.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-26 08:00 |
Regulatory News Service
Commercial update
|
English | 17.7 KB | |
| 2025-08-07 11:51 |
Regulatory News Service
ValiRx Awarded Grant from Open University
|
English | 16.2 KB | |
| 2025-08-05 10:53 |
M&A Activity
Update on Evaluation Agreement with Stingray Bio
|
English | 17.9 KB | |
| 2025-08-04 08:00 |
M&A Activity
Licensing Agreement with Dominion Biotech Ltd
|
English | 16.3 KB | |
| 2025-07-29 08:00 |
M&A Activity
Collaboration Agreement with Voxcell BioInnovation
|
English | 17.2 KB | |
| 2025-06-20 08:00 |
M&A Activity
Ambrose Exercise Option on VAL401
|
English | 16.9 KB | |
| 2025-06-06 11:54 |
Major Shareholding Notification
Holding(s) in Company
|
English | 54.3 KB | |
| 2025-06-06 08:00 |
Annual Report
Final Results & Notice of AGM
|
English | 174.1 KB | |
| 2025-06-03 08:00 |
Regulatory News Service
New Evaluation and Material Transfer Agreement
|
English | 15.3 KB | |
| 2025-03-27 08:00 |
Board/Management Information
Directorate Changes and new Advisory Board
|
English | 20.7 KB | |
| 2025-02-24 08:00 |
Regulatory News Service
Conclusion of Evaluation Project
|
English | 15.0 KB | |
| 2025-02-03 08:00 |
Regulatory News Service
Inaphaea Evaluation and Commercial Use Agreement
|
English | 17.0 KB | |
| 2025-01-30 08:00 |
M&A Activity
Extension of Evaluation Agreement
|
English | 15.0 KB | |
| 2025-01-29 08:00 |
M&A Activity
New Evaluation and Option Agreement
|
English | 15.5 KB | |
| 2025-01-15 13:47 |
Major Shareholding Notification
Holding(s) in Company
|
English | 22.1 KB |
Automate Your Workflow. Get a real-time feed of all VALIRX PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for VALIRX PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
